镁信健康作为“互联网+医+药+险”生态模式的创立者 ,镁信健康致力于通过创新医疗支付模式,打通患者、药企以及商保公司,推动金融工具与医疗领域的深度融合。
Employees: 201-500
Founded date: 2017
Investors 9
Mentions in press and media 6
| Date | Title | Description |
| 10.11.2025 | MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model | HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd... |
| 06.11.2025 | MediTrust Health Shares Insights at Hong Kong Fintech Week: AI Pragmatically Reshaping Cross-Border Healthcare Payments in the Greater Bay Area | HONG KONG, Nov. 6, 2025 /PRNewswire/ -- MediTrust Health, the largest innovative healthcare payor platform in China, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025." Seth Zhang, Founder and... |
| 28.02.2025 | Private Insurance Covered Just 7.7% of China's Novel Drug, Medical Device Costs in 2024 | (Yicai) Feb. 28 -- Commercial health insurance reimbursements only covered 7.7 percent of China's innovative drugs and medical devices market last year, with 49 percent coming from out-of-pocket payments and the rest covered by the national... |
| 14.03.2024 | Virtus Medical Group Announces New Strategic Investors | Shanghai Healthcare Capital, along with Mitsui and MediTrust, invest in and partner strategically with Virtus, cementing Virtus's Leadership in Private Healthcare Services, and Propelling Healthcare Innovation. HONG KONG, March 14, 2024 /PR... |
| 18.08.2021 | MediTrust Health scores $308M in Series C round | Credit: MediTrust |
| 11.08.2021 | Ant Group-backed MediTrust Health secures $300 million Series C | MediTrust Health, a Shanghai-based online healthcare payment and pharmacy platform, secured RMB 2 billion ($300) in Series C as the company plans for an IPO by the end of this year. Boyu Capital, Lillly Asia Ventures, and CICC participated ... |